Optimizing Patient Services for Biosimilars: Strategies for a Market Access-Driven Landscape

The evolving biosimilar market presents new challenges and opportunities for patient services. This white paper explores strategic approaches to enhance support programs in a cost-effective manner. It highlights key considerations for improving patient care and outlines flexible models for optimizing resource use. By adopting these strategies, biosimilar manufacturers can better navigate the complexities of the current market while maintaining a high standard of patient support.